Product

etoposide

Aliases

Etoposide Phosphate

Name

Etoposide

INN Name

etoposide phosphate

FDA Approved

Yes

1 clinical trial

3 organizations

1 indication

2 documents

Indication

Hodgkin lymphoma

Clinical trial

An Open-label, Uncontrolled, Multicenter Phase II Trial of MK-3475 (Pembrolizumab) in Children and Young Adults With Newly Diagnosed Classical Hodgkin Lymphoma With Inadequate (Slow Early) Response to Frontline Chemotherapy (KEYNOTE 667)

Status: Active (not recruiting), Estimated PCD: 2027-02-13

Organization

Hikma Pharmaceuticals USA Inc.

Document

DailyMed Label: Etoposide

Organization

Fresenius Kabi USA, LLC

Document

DailyMed Label: ETOPOPHOS

Organization